Login to Your Account

Alpharma Rethinks King's Bid, Agrees to be Acquired for $1.6B

By Jennifer Boggs

Tuesday, November 25, 2008
Two months after urging shareholders to reject a $37-per-share offer from King Pharmaceuticals Inc., Alpharma Inc. changed its mind and agreed to the merger, which values the specialty pharma firm at about $1.6 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription